The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 775-788

  Hall, Rebecca L ^a   Willgoss, Thomas ^a   Humphrey, Louise J ^a   Kongsø, Jens Harald ^b  

^a ADELPHI REAL WORLD   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Drug delivery devices; Memory function; Patient adherence; Reminder function; Self management

Indexed keywords

ASTHMA; CAREGIVER; DIABETES MELLITUS; DRUG DELIVERY DEVICE; DRUG DOSE REGIMEN; DRUG USE; HEALTH BEHAVIOR; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL HISTORY; MEDICATION COMPLIANCE; MOTIVATION; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT MONITORING; REMINDER SYSTEM; REVIEW; SELF CARE; SELF REPORT;

EID: 84901389390     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S61248     Document Type: Review

References (47)

1. World Health Organization (WHO). Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed April 23, 2014.
2. Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR. The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence. 2012;6:127-135.
3. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-47.
4. Gould E, Mitty E. Medication adherence is a partnership, medication compliance is not. Geriatri Nurs. 2010;31(4):290-298.
5. American Society on Aging and American Society of Consultant Pharmacist Foundation. Adult Meducation: Improving Medication Adherenced in Older Adults: Medication Adherence - Where We Are Today? 2006. Available from: http://www.adultmeducation.com/downloads/Adult_Meducation.pdf. Accessed January 7, 2013.
6. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-314.
7. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
8. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;(2):CD000011.
9. Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002;25(4):355-372.
10. Dunbar-Jacob J, Mortimer-Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54 Suppl 1:S57-S60.
11. Elliott RA, Shinogle JA, Peele P, Bhosle M, Hughes DA. Understanding medication compliance and persistence from an economics perspective. Value Health. 2008;11(4):600-610.
12. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
13. National Pharmaceutical Council. Noncompliance with medication regimens. An economic tragedy. Emerging issues in pharmaceutical cost containing. Washington, DC: National Pharmaceutical Council; 1992:1-16.
14. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657-665.
15. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331-342.
16. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
17. Krueger KP, Berger BA, Felkery B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22(4):313-356.
18. The Boston Consulting Group. The Hidden Epidemic: Finding a Cure for Unfilled Prescriptions and Missed Doses. Boston, MA: The Boston Consulting Group; 2003:1-8. Available at: http://www.bcg.com/documents/file14265.pdf. Accessed April 23, 2014.
19. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-1310.
20. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005;22(10):1379-1385.
21. Zgibor JC, Simmons D. Barriers to blood glucose monitoring in a multiethnic community. Diabetes Care. 2002;25(10):1772-1777.
22. Bayliss EA, Steiner JF, Fernald DH, Crane LA, Main DS. Descriptions of barriers to self-care by persons with comorbid chronic diseases. Ann Family Med. 2003;1(1):15-21.
23. Onwudiwe NC, Mullins CD, Winston RA, et al. Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics. Ethn Dis. 2011;21(1):27-32.
24. Funnell MM, Anderson RM. MSJAMA: the problem with compliance in diabetes. JAMA. 2000;284(13):1709.
25. McNabb WL. Adherence in diabetes: can we define it and can we measure it? Diabetes Care. 1997;20(2):215-218.
26. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177-187.
27. Walker EA, Usher JA. Understanding and enhancing adherence in adults with diabetes. Curr Diab Rep. 2003;3(2):141-148.
28. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
29. Randløv J, Poulsen JU. How much do forgotten insulin injections matter to hemoglobin a1c in people with diabetes? A simulation study. J Diabetes Sci Technol. 2008;2(2):229-235.
30. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413-420.
31. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772-779.
32. Fry A. Electronically enabled drug-delivery devices: are they part of the future? Ther Deliv. 2012;3(7):805-807.
33. Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19(5):696-704.
34. Adolfsson P, Veijola R, Huot C, Hansen HD, Lademann JB, Phillip M. Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes - the REMIND study. Curr Med Res Opin. 2012;28(9):1455-1463.
35. Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis. 2005;41(6):875-882.
36. Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy Clin Immunol. 2007;119(4):811-816.
37. Christensen A, Christrup LL, Fabricius PE, et al. Survey of patient and physician assessment of a compliance reminder device in the treatment of hypertension. Blood Press. 2009;18(5):280-285.
38. Dahlgren J, Veimo D, Johansson L, Bech I. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use. Curr Med Res Opin. 2007;23(7):1649-1655.
39. Danne T, Forst T, Deinhard J, Rose L, Moennig E, Haupt A. No effect of insulin pen with memory function on glycemic control in a patient cohort with poorly controlled type 1 diabetes: a randomized open-label study. J Diabetes Sci Technol. 2012;6(6):1392-1397.
40. Guo X, Sommavilla B, Vanterpool G, Qvist M, Bethien M, Lilleøre SK. Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals. Expert Opin Drug Deliv. 2012;9(4):355-356.
41. Ignaut DA, Venekamp WJ. HumaPen Memoir: a novel insulin-injecting pen with a dose-memory feature. Expert Rev Med Devices. 2007;4(6): 793-802.
42. Jansen A, Andersen KF, Brüning H. Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX) in a randomized, open-label, controlled study: an a priori subgroup analysis. Clin Ther. 2009;31(2):321-327.
43. Klausmann G, Hramiak I, Qvist M, Mikkelsen KH, Guo X. Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals. Patient Prefer Adherence. 2013;7:285-292.
44. Olsen BS, Lilleøre SK, Korsholm CN, Kracht T. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals. J Diabetes Sci Technol. 2010;4(6):1468-1475.
45. Santschi V, Wuerzner G, Schneider MP, Bugnon O, Burnier M. Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring. Eur J Clin Pharmacol. 2007;63(12):1179-1184.
46. Venekamp WJ, Kerr L, Dowsett SA, et al. Functionality and acceptability of a new electronic insulin injection pen with a memory feature. Curr Med Res Opin. 2006;22(2):315-325.
47. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336(7653):1114-1117.